AIDS

1. GHYS PD, Voetsch AC, Justman JE, Patel H, et al
   HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015-2022.
   AIDS. 2026 Feb 17. doi: 10.1097/QAD.0000000000004471.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

2. BUKRINSKY M, Segarra L, Alexander A, Rakhmanina N, et al
   Building Successful Career Trajectories for Early-Stage Investigators in HIV Research: Reflections from the DC CFAR My Path to Independence Series.
   AIDS Res Hum Retroviruses. 2026 Feb 18:8892229261426066.
   

   >> Share

   
   

   
   BMC Cancer

3. WANGUSI R, Ngugi E, Wafula S, Awuor P, et al
   Enhancing cervical cancer screening uptake through self-sampling for HPV DNA testing: insights and results from implementing in routine HIV clinics serving women living with HIV in Nairobi, Kenya, 2021-2024.
   BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15771.
   

   >> Share

   
   
4. CHEN R, Huo Z, Yang X, Cui X, et al
   The risk of infection-related malignancies and tumor mutational burden in immunocompromised hosts: a systematic review and meta-analysis.
   BMC Cancer. 2026 Feb 19. doi: 10.1186/s12885-026-15752.
   

   >> Share

   
   
5. ANENA S, Okello MO, Ouma RC, Olum R, et al
   Uptake of cervical cancer screening services among women of reproductive age enrolled in HIV care: a facility-based cross-sectional study in rural Northern Uganda.
   BMC Cancer. 2026 Feb 16. doi: 10.1186/s12885-026-15708.
   

   >> Share

   
   

   
   BMC Pediatr

6. MBAKAYA BC, Zgambo M, Moyo R, Kaseka PU, et al
   Psychosocial determinants of hand hygiene practices among children and adolescents living with HIV in the Northern city of Malawi.
   BMC Pediatr. 2026 Feb 18. doi: 10.1186/s12887-025-06147.
   

   >> Share

   
   

   
   Clin Infect Dis

7. HERBEL S, Paccoud O, de Montmollin E, Grenier B, et al
   Presentation and prognosis of cryptococcosis requiring intensive care unit admission in France: the CRYPTO-ICU study.
   Clin Infect Dis. 2026 Feb 18:ciag091. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

8. HESKIN J, Movahedi R, Kang S, Byrne R, et al
   The effect of Biktarvy (B/F/TAF) on whole-body insulin sensitivity, lipid and endocrine profile in healthy volunteers.
   HIV Med. 2026 Feb 18. doi: 10.1111/hiv.70208.
   

   >> Share

   
   
9. BRUNO S, Olivier R, Valerie P, Paul L, et al
   Treatment durability, satisfaction and quality of life in virologically suppressed HIV-1 people switching to doravirine: Results from the French study DoraVIH.
   HIV Med. 2026 Feb 19. doi: 10.1111/hiv.70210.
   

   >> Share

   
   

   
   J Am Acad Dermatol

10. GOODMAN W, Goldberg R, Hamann CR
    HIV-Related Exclusion Criteria in Cutaneous Cancer Clinical Trials.
    J Am Acad Dermatol. 2026 Feb 17:S0190-9622(26)00247.
    

    >> Share

    
    

    
    J Clin Invest

11. ELWY A, Abdelrahman H, Specht J, Ewert GM, et al
    Type I IFN-dependent FcgammaRIV signaling in murine monocytes promotes lethal anaphylaxis during viral infections.
    J Clin Invest. 2026;136:e192371.
    

    >> Share

    
    
12. BLAZKOVA J, Kennedy BD, Justement JS, Shi V, et al
    Characterization of elite controllers with undetectable intact HIV DNA reservoir.
    J Clin Invest. 2026 Feb 17:e202577. doi: 10.1172/JCI202577.
    

    >> Share

    
    
13. NIESAR A, Lancien M, Hong S, Naasz C, et al
    Immune correlates of HIV-1 rebound during broadly neutralizing antibody treatment in young children.
    J Clin Invest. 2026;136:e193912.
    

    >> Share

    
    

    
    J Infect Dis

14. MULENGA H, Mendelsohn SC, Fiore-Gartland A, Penn-Nicholson A, et al
    Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden setting.
    J Infect Dis. 2026 Feb 18:jiag100. doi: 10.1093.
    

    >> Share

    
    
15. ENGEL N, Dumond JB, Kashuba ADM, Cottrell ML, et al
    Optimizing On-Demand Tenofovir Disoproxil Fumarate/Emtricitabine Dosing in Women for HIV Prevention.
    J Infect Dis. 2026;233:257-260.
    

    >> Share

    
    
16. CHAN PA
    The contribution and importance of animal research to HIV prevention in the United States.
    J Infect Dis. 2026 Feb 17:jiag089. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

17. NEVES ES, Espindola OM, Oliveira RVC, Leite ACCB, et al
    Morbidity and Mortality Among People Living With HTLV-1: A 30-Year Retrospective Analysis in a Brazilian Cohort.
    J Med Virol. 2026;98:e70849.
    

    >> Share

    
    

    
    J Virol

18. DOCKEN SS, Macairan A, Schlub TE, Fennessey CM, et al
    Dissecting the steps in early simian immunodeficiency virus dissemination following mucosal and intravenous infection of rhesus macaques.
    J Virol. 2026 Feb 18:e0148525. doi: 10.1128/jvi.01485.
    

    >> Share

    
    

    
    Lancet Infect Dis

19. GARCIA-BUSTOS V, Puchades F, Alonso-Ecenarro F, Cabanero-Navalon MD, et al
    Development and validation of the AURIS score for predicting candidaemia in Candidozyma auris-colonised patients in the intensive care unit: a bicentric retrospective cohort study.
    Lancet Infect Dis. 2026 Feb 17:S1473-3099(26)00002.
    

    >> Share

    
    

    
    N Engl J Med

20. BAROCAS JA
    From Efficacy to Access in Long-Acting HIV Therapy.
    N Engl J Med. 2026 Feb 18. doi: 10.1056/NEJMe2518334.
    

    >> Share

    
    
21. RANA AI, Zheng L, Castillo-Mancilla J, Bao Y, et al
    Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges.
    N Engl J Med. 2026 Feb 18:10.1056/NEJMoa2508228. doi: 10.1056/NEJMoa2508228.
    

    >> Share

    
    

    
    Nature

22. SINGER MR, Li Z, Rey JS, Hope J, et al
    Integrase anchors viral RNA to the HIV-1 capsid interior.
    Nature. 2026 Feb 18. doi: 10.1038/s41586-026-10154.
    

    >> Share

    
    
23. SCHMIDT A, Alawathurage TM, David FS, Ogawa Y, et al
    Host control of persistent Epstein-Barr virus infection.
    Nature. 2026 Feb 19. doi: 10.1038/s41586-026-10274.
    

    >> Share

    
    

    
    PLoS One

24. ZHANG H, Yuan S, Ding S, Bao H, et al
    Molecular interplay of ASNS and the PI3K-AKT-mTOR pathway in CMV and HIV co-infections: Therapeutic implications.
    PLoS One. 2026;21:e0342050.
    

    >> Share

    
    
25. REHMAN N, Mbuagbaw L, Mertz D, Muraca GM, et al
    Socioeconomic determinants of virtual care use among people living with HIV in a clinical cohort in Ontario, Canada: A cross-sectional study.
    PLoS One. 2026;21:e0326989.
    

    >> Share

    
    
26. NIWAGABA S, Muyunga A, Bulafu D, Nakanwagi JL, et al
    Herbal medicine use and renal dysfunction among persons living with HIV on Tenofovir-based ART in Kampala, Uganda.
    PLoS One. 2026;21:e0343124.
    

    >> Share

    
    
27. BLANCO JR, Torralba M, Saumoy M, Alcaraz A, et al
    Longitudinal changes in circulating biomarkers from baseline to week 48 in treatment-Naive people living with HIV initiating integrase inhibitor-based antiretroviral therapy.
    PLoS One. 2026;21:e0343230.
    

    >> Share

    
    
28. LAWAL O, Okon M, Blanco N, Riley C, et al
    Place susceptibility index mapping at local government scale from population-based survey for Sub-Saharan Africa.
    PLoS One. 2026;21:e0340782.
    

    >> Share

    
    
29. MOUTOMBI DITOMBI BC, Manomba Boulingui C, Mbang Nguema OA, Mihindou CJ, et al
    Clinical and biological features of complicated and asymptomatic malaria among PLHIV and HIV-negative adults: An observational study in Libreville, Gabon.
    PLoS One. 2026;21:e0327068.
    

    >> Share

    
    

    
    Vaccine

30. HENG F, Magaret CA, Rouphael NG, Branche AR, et al
    The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances.
    Vaccine. 2026;76:128348.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share